Extended Cardiac Arrest in Severe Bupropion Intoxication: All the Information You Need to Know About Extracorporeal Membrane Oxygenation, Transesophageal Echocardiography-Guided Resuscitation, and Anti-Arrhytmics

Authors

  • Caitlin Celis Department of Emergency Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
  • Melvin Willems Department of Emergency Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
  • Ben Pellens Department of Emergency Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
  • Stefanie Vandervelden Department of Emergency Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium

Keywords:

Bupropion, Intoxication, Extracorporeal membrane oxygenation, TEE guided resuscitation, Antiarrhythmic therapy

Abstract

A 30-year-old woman was admitted to the emergency department one and half hours after severe bupropion extended-release intoxication, estimated to be between 18 and 36 g. She initially presented with seizures and later developed signs of cardiotoxicity with persisting sustained ventricular tachycardia. Despite multiple defibrillation attempts and the administration of sodium bicarbonate, calcium gluconate and magnesium, restoration of sinus rhythm was found unsuccessful. In another attempt to treat this refractory ventricular tachycardia lidocaine was given followed by deterioration to asystole. During cardiopulmonary resuscitation (CPR), the quality of chest compression was assessed and optimised using transoesophageal echocardiography. Eventually venoarterial extracorporeal membrane oxygenation (VA-ECMO) was needed to achieve hemodynamic stability. In this case report we discuss the successful use of VA-ECMO after bupropion intoxication, which has only been reported in 3 other cases but should be considered as one of the treatment options in severe overdose cases. Also, the rare complication of asystole after lidocaine administration and the value of transoesophageal echocardiography during CPR will be discussed.

References

Zhu Y, Kolawole T, Jimenez XF. Atypical findings in massive bu-propion overdose: A case report and discussion of psychopharma-cologic issues. J Psychiatr Pract. 2016; 22(5): 405-409. doi: 10.1097/ PRA.0000000000000179

Jefferson JW, Pradko JF, Muir KT. Bupropion for major depres-sive disorder: Pharmacokinetic and formulation considerations. 2005; 27:1685-95. doi: 10.1016/j.clinthera.2005.11.011

Costa R, Oliveira NG, Dinis-Oliveira RJ. Drug metabolism re-views pharmacokinetic and pharmacodynamic of bupropion: in-tegrative overview of relevant clinical and forensic aspects Phar-macokinetic and pharmacodynamic of bupropion: Integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019; 51(3): 293-313. doi: 10.1080/03602532.2019.1620763

Donnelly K, Walkowiak HB, Donnelly C, Jenkinson E, Rizkalla J, Langford N. Bupropion toxicokinetic: A case report. Clin Toxicol. 2010; 48(4): 385-387. doi: 10.3109/15563651003623289

Heise CW, Skolnik AB, Raschke RA, Owen-Reece H, Graeme KA. Two cases of refractory cardiogenic shock secondary to bu-propion successfully treated with veno-arterial extracorporeal membrane oxygenation. J Med Toxicol. 2016; 12(3): 301-304. doi: 10.1007/s13181-016-0539-7

Shenoi AN, Gertz SJ, Mikkilineni S, Kalyanaraman M. Refrac-tory hypotension from massive bupropion overdose successfully treated with extracorporeal membrane oxygenation. Pediatr Emerg Care. 2011; 27(1): 43-45. doi: 10.1097/PEC.0b013e3182045f76

Applebaum D, Halperin E. Asystole following a conventional therapeutic dose of lidocaine. Am J Emerg Med. 1986; 4(2): 143- 145. doi: 10.1016/0735-6757(86)90160-9

Manyari-Ortega DE, Brennan FJ. Lidocaine-induced cardiac asystole. Chest. 1978; 74(2): 227-229. doi: 10.1378/chest.74.2.227

Schmit G, De Boosere E, Vanhaebost J, Capron A. Bupropi-on overdose resulted in a pharmacobezoar in a fatal bupropion (Wellbutrin®) sustained-release overdose: Postmortem distribution of bupropion and its major metabolites. J Forensic Sci. 2017; 62(6): 1674-1676. doi: 10.1111/1556-4029.13497

Jepsen F, Matthews J. Sustained release bupropion overdose: an important cause of prolonged symptoms after an overdose. Emerg Med J. 2003; 20: 560-561. doi: 10.1136/emj.20.6.560

Stall N, Godwin J, Juurlink D. Five things to know about ⋯: Bupropion abuse and overdose. CMAJ. 2014; 186(13): 1015. doi: 10.1503/cmaj.131534

Greene S, Harris C, Singer J. Gastrointestinal decontamination of the poisoned patient. Pediatr Emerg Care. 2008; 24(3): 176-186. doi: 10.1097/PEC.0b013e318166a092 Vandervelden S et al

Zellner T, Prasa D, Färber E, Hoffmann-Walbeck P, Genser D, Eyer F. The use of activated charcoal to treat intoxications. Dtsch Arztebl Int. 2019; 116(18): 311-317. doi: 10.3238/arztebl.2019.0311

Bornstein K, Montrief T, Anwar Parris M. Successful man-agement of adolescent bupropion overdose with intravenous lipid emulsion therapy. J Pediatr Intensive Care. 2019; 8(4): 242-246. doi: 10.1055/s-0039-1693483

Herrman NWC, Kalisieski MJ, Fung C. Bupropion overdose complicated by cardiogenic shock requiring vasopressor support and lipid emulsion therapy. J Emerg Med. 2020; 58(2): e47-e50. doi: 10.1016/j.jemermed.2019.11.029

Chhabra N, DesLauriers C, Wahl M, Bryant SM. Management of severe bupropion poisoning with intravenous lipid emulsion. Clin Toxicol. 2018; 56(1): 51-54. doi: 10.1080/15563650.2017.1337909

Morazin F, Lumbroso A, Harry P, Blaise M, Turcant A, Mon-travers P, et al. Cardiogenic shock and status epilepticus after mas-sive bupropion overdose. Clin Toxicol. 2007; 45(7): 794-797. doi: 10.1080/15563650701665076

Stewart E, Grewal K, Hudson H, Thompson M, Godwin J. Clinical characteristics and outcomes associated with bupropion overdose: A Canadian perspective. Clin Toxicol. 2019; 58(8): 837- 842. doi: 10.1080/15563650.2019.1699658

Spiller HA, Ramoska EA, Krenzelok EP, Sheen SR, Borys DJ, Villalobos D, et al. Bupropion overdose: A 3-year multi-center retrospective analysis. Am J Emerg Med. 1994; 12(1): 43-45. doi: 10.1016/0735-6757(94)90195-3

Franco V. Wide complex tachycardia after bupropion over-dose. Am J Emerg Med. 2012; 32(3): 1540. e3-5. doi: 10.1016/j. ajem.2015.07.063

Paris PA, Saucier JR. ECG conduction delays associated with massive bupropion overdose. J Toxicol Clin Toxicol. 1998; 36(6): 595- 598. doi: 10.3109/15563659809028055

Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother. 2003; 37(7-8): 999- 1002. doi: 10.1345/aph.1C481

Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: A case series. Med J Aust. 2003; 178(2): 61-63. doi: 10.5694/j.1326- 5377.2003.tb05064.x

Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Original contribution incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009; 27: 911-915. doi: 10.1016/j.ajem.2008.07.004

Daubin C, Lehoux P, Ivascau C, Tasle M, Bousta M, Lepage O, et al. Extracorporeal life support in severe drug intoxication: A ret-rospective cohort study of seventeen cases. Crit Care. 2009; 13(4): R138. doi: 10.1186/cc8017

Masson R, Colas V, Parienti J-J, Lehoux P, Massetti M, Char-bonneau P, et al. A comparison of survival with and without extra-corporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012; 83(11): 1413-1417. doi: 10.1016/j. resuscitation.2012.03.028

Kedan I, Ciozda W, Palatinus JA, Palatinus HN, Kimchi A. Prognostic value of point-of-care ultrasound during cardiac ar-rest: A systematic review. Cardiovasc Ultrasound. 2020; 18(1): 1. doi: 10.1186/s12947-020-0185-8

Teran F, Dean AJ, Centeno C, Panebianco NL, Zeidan AJ, Chan W, et al. Evaluation of out-of-hospital cardiac arrest us-ing transesophageal echocardiography in the emergency depart-ment. Resuscitation. 2019; 137: 140-147. doi: 10.1016/j.resuscita-tion.2019.02.013

Mayo PH, Narasimhan M, Koenig S. Critical care trans-esophageal echocardiography. Chest. 2015; 148(5): 1323-1332. doi: Submit your article to this journal | https://openventio.org/submit-manuscript/ 10.1378/chest.15-0260

Labovitz AJ, Noble VE, Bierig M, Goldstein SA, Jones R, Kort S, et al. Focused cardiac ultrasound in the emergent setting: A con-sensus statement of the American society of Echocardiography and American College of Emergency Physicians. J Am Soc Echo-cardiogr. 2010; 23(12): 1225-1230. doi: 10.1016/j.echo.2010.10.005

Monsieurs KG, Nolan JP, Bossaert LL, Greif R, Maconochie IK, Nikolaou NI, et al. European resuscitation council guidelines for resuscitation 2015: Section 1. Executive summary. Resuscitation. 2015; 95: 1-80. doi: 10.1016/j.resuscitation.2015.07.038

Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, et al. Drug-induced arrhythmias: A scientific state-ment from the American Heart Association. Circulation. 2020; 142: e214-e233. doi: 10.1161/CIR.0000000000000905

Curry SC, Kashani JS, LoVecchio F, Holubek W. Intraventricular conduction delay after bupropion overdose. The Journal of Emergency Medicine. 2005; 29: 299-305. doi: 10.1016/j.jemermed.2005.01.027

Downloads

Published

2025-01-06

How to Cite

Caitlin Celis, Melvin Willems, Ben Pellens, & Stefanie Vandervelden. (2025). Extended Cardiac Arrest in Severe Bupropion Intoxication: All the Information You Need to Know About Extracorporeal Membrane Oxygenation, Transesophageal Echocardiography-Guided Resuscitation, and Anti-Arrhytmics. Emergency Medicine, 11(1), 1–6. Retrieved from https://openventio.us/index.php/EM/article/view/1950